3.12  -0.055 (-1.73%)		07-18 16:00
Open: 3.23 High: 3.23 Volume: 56,375		Pre. Close: 3.175 Low: 3.09 Market Cap: 111(M)

Short term
Mid term
Targets	6-month :	6.62	1-year :	8.48
Resists	First :	5.66	Second :	7.26
Pivot price	3.56
Supports	First :	3.08	Second :	2.57
MAs	MA(5) :	3.16	MA(20) :	4.15
	MA(100) :	4.94	MA(250) :	5.87
MACD	MACD :	-0.6	Signal :	-0.5
%K %D	K(14,3) :	1.6	D(3) :	1.3
RSI	RSI(14): 35.8
52-week	High :	13.52	Low :	1.04

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ BDMD ] has closed above bottom band by 16.1%. Bollinger Bands are 45.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	3.23 - 3.25	3.25 - 3.27
Low:	3.05 - 3.07	3.07 - 3.09
Close:	3.09 - 3.12	3.12 - 3.15

Baird Medical Investment Holdings Limited, together with its subsidiaries develops and sells microwave ablation medical devices for minimally invasive tumor treatment in China. The company's medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Baird Medical Investment Holdings Limited was founded in 2012 and is headquartered in Guangzhou, China.

Sat, 28 Jun 2025
InvestingPro’s Fair Value model captures Baird Medical’s 5-month correction By Investing.com - Investing.com

Thu, 26 Jun 2025
Why Worthington Steel Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket - Benzinga

Thu, 26 Jun 2025
Worthington Steel Shares Jump 15.7% After Beating Earnings Expectations - AInvest

Mon, 05 May 2025
Baird Medical to Participate in COSM 2025 Conference - BioSpace

Wed, 19 Mar 2025
Baird Medical Investment wins award for its cancer-surgery robot - Mugglehead Magazine

Tue, 21 Jan 2025
Dr. Emad Kandil Achieves Milestone of 100 Microwave Ablation Cases in Thyroid Care - PR Newswire

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Devices
Shares Out	37 (M)
Shares Float	1 (M)
Held by Insiders	99.9 (%)
Held by Institutions	1.3 (%)
Shares Short	75 (K)
Shares Short P.Month	20 (K)

EPS	0.49
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	1.54
Profit Margin	33.6 %
Operating Margin	42.7 %
Return on Assets (ttm)	14.2 %
Return on Equity (ttm)	33.3 %
Qtrly Rev. Growth	20 %
Gross Profit (p.s.)	0.88
Sales Per Share	1
EBITDA (p.s.)	0.44
Qtrly Earnings Growth	-0.4 %
Operating Cash Flow	-6 (M)
Levered Free Cash Flow	-4 (M)

PE Ratio	6.36
PEG Ratio	0
Price to Book value	2.01
Price to Sales	3.11
Price to Cash Flow	-18.31

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.